Sitagliptin phosphate (Monohydrate)
| Product Name | Sitagliptin phosphate (Monohydrate) |
|---|---|
| Alternate Names | Sitagliptin Impurities, Impurities of Sitagliptin |
| CAT No. | CS-O-02387 |
| CAS No. | 654671-77-9 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 523.32 g/mol |
| Mol. For. | C₁₆H₂₀F₆N₅O₆P |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Sitagliptin |
| Purity | >98% |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Sitagliptin phosphate monohydrate is a medication used to treat type 2 diabetes. It belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors, which work by increasing insulin secretion and reducing the production of glucose in the liver. Sitagliptin phosphate is usually taken orally once a day, with or without food.
Chemically, sitagliptin phosphate monohydrate is a white to off-white crystalline powder that is soluble in water. Its chemical formula is C16H15F6N5O·H3PO4·H2O, and its molecular weight is 523.32 g/mol. The monohydrate form of sitagliptin phosphate is a stable and highly soluble form of the drug.
Studies have shown that sitagliptin phosphate monohydrate is effective in reducing hemoglobin A1c levels, which is a marker of long-term blood sugar control. It has also been shown to be well-tolerated and safe for use in patients with type 2 diabetes. However, like all medications, sitagliptin phosphate monohydrate may have side effects, such as nausea, vomiting, and diarrhea.
In conclusion, sitagliptin phosphate monohydrate is a medication used to treat type 2 diabetes by increasing insulin secretion and reducing glucose production in the liver. It is a stable and highly soluble form of the drug that is well-tolerated and safe for use in patients with type 2 diabetes.
Get an Instant Quote
Related Compounds
Sitagliptin hydroxylimine impurity | SITAGLIPTIN FORMIC ACID ADDUCT | Sitagliptin Pyrazine Impurity | Sitagliptin FP Impurity D | Sitagliptin impurity H Hydrochloride | Sitagliptin impurity-4 | Sitagliptin dioxo impurity | Sitagliptin Enamine Impurity | Sitagliptin impurity I | Sitagliptin Impurity 61 | Sitagliptin Triazecine Analog-D4 | Sitagliptin Amino Acid Impurity | Sitagliptin impurity D | Sitagliptin Styrylacetyl Analogue | Sitagliptin impurity R | Sitagliptin FP Impurity D (Z)-Isomer | Sitagliptin impurity F | Sitagliptin N-Acetyl Impurity | Sitagliptin impurity J | Sitagliptin Amide impurity | Sitagliptin N-formyl impurity | Sitagliptin impurity N | Sitagliptin Impurity H | Oxo Sitagliptin | Sitagliptin Phosphate Hydrate | Sitagliptin Triazecine Analog | N-Nitroso Sitagliptin Fumarate Adduct | Sitagliptin Impurity 28 | Sitagliptin Impurity 62 | Sitagliptin Impurity 40 | Sitagliptin Impurity 93 | Rac-Sitagliptin Triazecine Analog | Sitagliptin Fumarate Adduct | Sitagliptin Acid Pivaloyl impurity | Sitagliptin EP Impurity C Phosphate | Sitagliptin isopropyl ester impurity | Sitagliptin Dioxo SODIUM Impurity | Sitagliptin EP Impurity C | Sitagliptin EP Impurity E | Sitagliptin EP Impurity A | Sitagliptin tartrate hemihydrate | Sitagliptin impurity T | Sitagliptin impurity K | Sitagliptin Impurity 84 | Nitroso Sitagliptin | Sitagliptin nitroso impurity | Sitagliptin impurity G | Sitagliptin impurity L | Sitagliptin EP Impurity C | Sitagliptin Impurity 39 |